STT3A and liposarcoma: siRNA targeting STT3A was transfected into human rhabdomyosarcoma cell line A673 and human liposarcoma cell line SW872 to knockdown STT3A, and the gene silencing effect was confirmed by qPCR, assessing the mRNA expression levels in the knockdown group compared to siNC group.